期刊文献+

运用计算模拟技术揭示黄芩素抗HIV的新机制(英文) 被引量:5

Insight into the new mechanism of the anti-HIV effect of baicalein by computational simulation
原文传递
导出
摘要 【目的】运用计算模拟技术,在分子水平揭示黄芩素抗HIV的新机制。【方法】基于药效团和分子对接等数据库搜索方法对抗HIV中药化学成分数据库进行虚拟筛选,得到潜在的抗HIV-1活性化合物;然后,利用分子对接技术得到抑制剂与靶蛋白的最佳结合模式,并从分子水平揭示其作用机制。【结果】虚拟筛选证实黄芩素是HIV-1逆转录酶和整合酶的抑制剂,分子对接显示其作用于HIV-1逆转录酶的核糖核酸酶H区域和整合酶的疏水区域。【结论】黄芩素是一个具有二价金属离子作用机制的、针对HIV-1核糖核酸酶H和整合酶的双重抑制剂。 [Objective] In order to insight into the new mechanism of the anti-HIV effect of baicalein by computational simulation at molecular level. [ Methods ] Based on pharmacophore and molecular docking, some potential anti-HIV-1 active compounds would be found in the anti-HIVTCMCD. With molecular docking technique, the binding modes between inhibitors and theirs target enzymes would be built, and their mechanisms would be revealed at molecular level. [ Result] It is proved that baicalein can inhibit HIV-1 through binding to RNase H region of HHIV-1 RT and the hydrophobic region of HIV-1IN. [Conclusion]Baicalein is a dual inhibitor against both HIV-1 RNase H and IN.
出处 《武警后勤学院学报(医学版)》 CAS 2013年第9期753-755,F0004,共4页 Journal of Logistics University of PAP(Medical Sciences)
基金 国家自然科学基金项目(81241114,30472166) 天津市科技攻关计划重点科技攻关专项基金资助项目(06YFGZSH07000)
关键词 HIV-1 核糖核酸酶H 整合酶 逆转录酶 作用机制 HIV-1 Ribonuclease H Intergrase Reverse transcriptase Mechanism
  • 相关文献

参考文献8

二级参考文献30

  • 1Allison, A. J.; Christophe, M.; Sachindra S. P.; Robert, C.; Robert, D. S.; Terrence, R. B.; Yves, P. Molecular Pharmacology 2007, 71,893-901.
  • 2Clore, G. M.; Cai, M.; Caffrey, M.; Gronenborn, A. M. Nat. Struct. Biol. 1997, 4, 567-577.
  • 3Goldgur, Y.; Dyda, E; Hickman, A. B.; Jenkins, T. M.; Craigie, R.; Davies, D. R. proc. Natl. Acad. Sci. USA 1998, 95, 9150-9154.
  • 4Eijkelenboom, A. P. A. M.; Sprangers, R.; Hard, K.; Puras Lutzke, R. A.; Plasterk, R. H. A.; Boelens, R.; Kaptein, R. Proteins: Struct. Funct. Genet. 1999, 36, 556-564.
  • 5Goldgur, Y.; Craigie, R.; Fujiwara, T.; Yoshinaga, T.; Davies, D. R. Proc. Natl. Acad. Sci. USA 1999, 96, 13040-13043.
  • 6Drake, R. R.; Neamati, N.; Hong, H.; Pilon, A. A.; Sunthankar, P.; Hume, S. D.; Milne, G. W. A.; Pommier, A. Y. Natl. Acad. Sci. USA 1998, 95, 4170-4175.
  • 7Hazuda, D. J.; Anthony, N. J., Gomez, R. P.; Jolly, S. M.; Wai, J. S.; Zhuang, L. H.; Fisher, T. E.; Embrey, M; Guare, J. P.; Egbertson, M. S.; Vacca, J. P.; Huff, J. R.; Felock, P. J.; Witmer, M. V.; Stillmock, K. A.; Danovich, R.; Grobler, J.; Miller, M. D.; Espeseth, A.; Jin, L. X.; Chen, I. W.; Lin, J. H.; Kassahun, K; Ellis, J. D.; Wong, B.K; Xu, W.; Pearson, P. G; Schleif, W. A.; Cortese, R; Emini, E.; Summa, V.; Holloway, M. K.; Young, S. D. PARAS. 2004, 31, 11233-11238.
  • 8Markowitz, M.; Morales, R. J.; Nguyen, B. Y.; Kovacs, C. M.; Steigbigel, R. T.; Copper, D. A.; Liporace, R.; Schwartz, R.; Isaacs, R.; Gilde, L. R; Wenning, L.; Zhao, J.; Teppler,G. Acquir. Immune. Defic. Syndr. 2006, 5,509-515.
  • 9Khedkar, S. A; Malde, A. K; Coutinho, E. C.; Srivastava, S. Med. Chem. 2007, 3, 187-197.
  • 10Gordon, C. P.; Griffith, R; Keller, P. A. Faculty of Science 2007, 3, 1-40.

共引文献87

同被引文献115

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部